| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1C ABCC4 IPO8 SLC16A9 MFSD2B PANX1 OCA2 SPNS3 SLC7A11 SLC1A4 SLC1A5 KCNV1 SLC6A6 SLC9A4 SLC9A2 SLC7A3 CLCA2 SLC15A1 SCN1A SCN2A KCNJ11 GLRB SLC35D3 SLC49A4 SCN9A SCN10A ABCC12 NALF2 SLC22A20P | 1.09e-12 | 1180 | 104 | 29 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | CACNA1C ABCC4 IPO8 SLC16A9 MFSD2B PANX1 OCA2 SPNS3 SLC7A11 SLC1A4 SLC1A5 KCNV1 SLC6A6 SLC9A4 SLC9A2 SLC7A3 CLCA2 SLC15A1 SCN1A SCN2A KCNJ11 GLRB SLC35D3 SLC49A4 SCN9A SCN10A ABCC12 NALF2 SLC22A20P | 9.54e-12 | 1289 | 104 | 29 | GO:0005215 |
| GeneOntologyMolecularFunction | inhibitory MHC class I receptor activity | 2.68e-09 | 12 | 104 | 5 | GO:0032396 | |
| GeneOntologyMolecularFunction | HLA-A specific inhibitory MHC class I receptor activity | 3.46e-09 | 5 | 104 | 4 | GO:0030107 | |
| GeneOntologyMolecularFunction | HLA-B specific inhibitory MHC class I receptor activity | 1.03e-08 | 6 | 104 | 4 | GO:0030109 | |
| GeneOntologyMolecularFunction | MHC class Ib protein complex binding | 2.40e-08 | 7 | 104 | 4 | GO:0023025 | |
| GeneOntologyMolecularFunction | MHC class I receptor activity | 2.82e-08 | 18 | 104 | 5 | GO:0032393 | |
| GeneOntologyMolecularFunction | MHC class Ib receptor activity | 3.82e-08 | 19 | 104 | 5 | GO:0032394 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1C ABCC4 PANX1 OCA2 SLC1A4 KCNV1 SLC6A6 SLC9A4 SLC9A2 CLCA2 SLC15A1 SCN1A SCN2A KCNJ11 GLRB SCN9A SCN10A NALF2 | 6.80e-08 | 758 | 104 | 18 | GO:0015318 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCC4 IPO8 SLC16A9 MFSD2B SLC7A11 SLC1A4 SLC1A5 SLC6A6 SLC9A4 SLC9A2 SLC15A1 KCNJ11 SLC35D3 ABCC12 | 1.82e-07 | 477 | 104 | 14 | GO:0022804 |
| GeneOntologyMolecularFunction | IgM binding | 2.23e-07 | 11 | 104 | 4 | GO:0001791 | |
| GeneOntologyMolecularFunction | channel activity | CACNA1C PANX1 OCA2 SLC1A4 SLC1A5 KCNV1 CLCA2 SCN1A SCN2A KCNJ11 GLRB SCN9A SCN10A NALF2 | 5.78e-07 | 525 | 104 | 14 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1C PANX1 OCA2 SLC1A4 SLC1A5 KCNV1 CLCA2 SCN1A SCN2A KCNJ11 GLRB SCN9A SCN10A NALF2 | 5.91e-07 | 526 | 104 | 14 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1C PANX1 OCA2 SLC1A4 KCNV1 SLC6A6 SLC9A4 SLC9A2 CLCA2 SLC15A1 SCN1A SCN2A KCNJ11 GLRB SCN9A SCN10A NALF2 | 6.90e-07 | 793 | 104 | 17 | GO:0015075 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1C PANX1 OCA2 SLC1A4 KCNV1 CLCA2 SCN1A SCN2A KCNJ11 GLRB SCN9A SCN10A NALF2 | 7.72e-07 | 459 | 104 | 13 | GO:0005216 |
| GeneOntologyMolecularFunction | MHC class Ib protein binding | 1.20e-06 | 16 | 104 | 4 | GO:0023029 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 1.57e-06 | 17 | 104 | 4 | GO:0099508 | |
| GeneOntologyMolecularFunction | MHC protein complex binding | 2.25e-06 | 41 | 104 | 5 | GO:0023023 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | ABCC4 SLC16A9 PANX1 SLC7A11 SLC1A4 SLC1A5 SLC6A6 SLC7A3 SLC35D3 SLC22A20P | 3.07e-06 | 293 | 104 | 10 | GO:0008514 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC16A9 MFSD2B SLC7A11 SLC1A4 SLC1A5 SLC6A6 SLC9A4 SLC9A2 SLC15A1 SLC35D3 | 3.36e-06 | 296 | 104 | 10 | GO:0015291 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR51T1 OR2T29 LILRA1 LILRA3 LILRA2 OR10A2 LILRB2 OR52L1 DNER OR13G1 OR2T5 OR2T10 ACVR1C PTGFR LILRB1 OR52J3 LMBR1L OR4A16 GLRB KLRC1 OR10A5 | 5.41e-06 | 1353 | 104 | 21 | GO:0004888 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1C PANX1 KCNV1 SLC6A6 SLC9A4 SLC9A2 SCN1A SCN2A KCNJ11 SCN9A SCN10A NALF2 | 5.49e-06 | 465 | 104 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 9.50e-06 | 26 | 104 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 9.50e-06 | 26 | 104 | 4 | GO:0031420 | |
| GeneOntologyMolecularFunction | gated channel activity | CACNA1C SLC1A5 KCNV1 CLCA2 SCN1A SCN2A KCNJ11 GLRB SCN10A NALF2 | 9.73e-06 | 334 | 104 | 10 | GO:0022836 |
| GeneOntologyMolecularFunction | protein phosphatase binding | 1.42e-05 | 210 | 104 | 8 | GO:0019903 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 2.23e-05 | 32 | 104 | 4 | GO:0042288 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1C PANX1 KCNV1 SLC6A6 SLC9A4 SLC9A2 SLC15A1 SCN1A SCN2A KCNJ11 SCN9A SCN10A NALF2 | 2.27e-05 | 627 | 104 | 13 | GO:0022890 |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 2.53e-05 | 33 | 104 | 4 | GO:0072349 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 3.16e-05 | 171 | 104 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | protein phosphatase 1 binding | 3.21e-05 | 35 | 104 | 4 | GO:0008157 | |
| GeneOntologyMolecularFunction | immunoglobulin binding | 3.60e-05 | 36 | 104 | 4 | GO:0019865 | |
| GeneOntologyMolecularFunction | coreceptor activity | 3.69e-05 | 72 | 104 | 5 | GO:0015026 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1C PANX1 KCNV1 SLC6A6 SLC9A4 SLC9A2 SLC15A1 SCN1A SCN2A KCNJ11 SCN9A SCN10A NALF2 | 4.11e-05 | 664 | 104 | 13 | GO:0008324 |
| GeneOntologyMolecularFunction | sodium ion binding | 4.79e-05 | 14 | 104 | 3 | GO:0031402 | |
| GeneOntologyMolecularFunction | phosphatase binding | 7.24e-05 | 264 | 104 | 8 | GO:0019902 | |
| GeneOntologyMolecularFunction | protein antigen binding | 7.32e-05 | 16 | 104 | 3 | GO:1990405 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 7.32e-05 | 83 | 104 | 5 | GO:0015101 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 7.69e-05 | 343 | 104 | 9 | GO:0005261 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR51T1 OR2T29 OR10A2 OR52L1 OR13G1 OR2T5 OR2T10 OR52J3 OR4A16 OR10A5 | 8.47e-05 | 431 | 104 | 10 | GO:0004984 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.06e-04 | 207 | 104 | 7 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.09e-04 | 208 | 104 | 7 | GO:0005342 | |
| GeneOntologyMolecularFunction | symporter activity | 1.35e-04 | 150 | 104 | 6 | GO:0015293 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.40e-04 | 151 | 104 | 6 | GO:0008509 | |
| GeneOntologyMolecularFunction | acidic amino acid transmembrane transporter activity | 1.47e-04 | 20 | 104 | 3 | GO:0015172 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.55e-04 | 52 | 104 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | SH2 domain binding | 1.55e-04 | 52 | 104 | 4 | GO:0042169 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 2.03e-04 | 103 | 104 | 5 | GO:0005253 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 2.22e-04 | 105 | 104 | 5 | GO:0015171 | |
| GeneOntologyMolecularFunction | immune receptor activity | 2.26e-04 | 165 | 104 | 6 | GO:0140375 | |
| GeneOntologyMolecularFunction | MHC protein binding | 2.37e-04 | 58 | 104 | 4 | GO:0042287 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 2.74e-04 | 171 | 104 | 6 | GO:0015103 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 2.88e-04 | 61 | 104 | 4 | GO:1901682 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 3.83e-04 | 182 | 104 | 6 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 4.06e-04 | 184 | 104 | 6 | GO:0022832 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 4.97e-04 | 125 | 104 | 5 | GO:0015108 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 5.16e-04 | 71 | 104 | 4 | GO:0015179 | |
| GeneOntologyMolecularFunction | antiporter activity | 7.79e-04 | 138 | 104 | 5 | GO:0015297 | |
| GeneOntologyMolecularFunction | tripeptide transmembrane transporter activity | 9.44e-04 | 9 | 104 | 2 | GO:0042937 | |
| GeneOntologyMolecularFunction | L-serine transmembrane transporter activity | 9.44e-04 | 9 | 104 | 2 | GO:0015194 | |
| GeneOntologyMolecularFunction | L-glutamine transmembrane transporter activity | 9.44e-04 | 9 | 104 | 2 | GO:0015186 | |
| GeneOntologyMolecularFunction | chloride channel activity | 1.06e-03 | 86 | 104 | 4 | GO:0005254 | |
| GeneOntologyMolecularFunction | L-aspartate transmembrane transporter activity | 1.18e-03 | 10 | 104 | 2 | GO:0015183 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.26e-03 | 90 | 104 | 4 | GO:0008028 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 1.27e-03 | 41 | 104 | 3 | GO:0015175 | |
| GeneOntologyMolecularFunction | sulfur amino acid transmembrane transporter activity | 1.43e-03 | 11 | 104 | 2 | GO:0000099 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 2.00e-03 | 102 | 104 | 4 | GO:0001540 | |
| GeneOntologyMolecularFunction | potassium:proton antiporter activity | 2.35e-03 | 14 | 104 | 2 | GO:0015386 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.54e-03 | 109 | 104 | 4 | GO:0042626 | |
| GeneOntologyMolecularFunction | C4-dicarboxylate transmembrane transporter activity | 2.70e-03 | 15 | 104 | 2 | GO:0015556 | |
| GeneOntologyMolecularFunction | sodium:proton antiporter activity | 3.07e-03 | 16 | 104 | 2 | GO:0015385 | |
| GeneOntologyMolecularFunction | alanine transmembrane transporter activity | 3.07e-03 | 16 | 104 | 2 | GO:0022858 | |
| GeneOntologyMolecularFunction | oligopeptide transmembrane transporter activity | 3.07e-03 | 16 | 104 | 2 | GO:0035673 | |
| GeneOntologyMolecularFunction | antigen binding | 3.18e-03 | 190 | 104 | 5 | GO:0003823 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 3.61e-03 | 59 | 104 | 3 | GO:0015932 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 4.34e-03 | 19 | 104 | 2 | GO:0022821 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 4.80e-03 | 20 | 104 | 2 | GO:0061665 | |
| GeneOntologyMolecularFunction | sialyltransferase activity | 5.29e-03 | 21 | 104 | 2 | GO:0008373 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR51T1 OR2T29 OR10A2 OR52L1 OR13G1 OR2T5 OR2T10 PTGFR OR52J3 OR4A16 OR10A5 | 6.32e-03 | 884 | 104 | 11 | GO:0004930 |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 8.66e-03 | 27 | 104 | 2 | GO:0051139 | |
| GeneOntologyBiologicalProcess | interleukin-10-mediated signaling pathway | 1.27e-09 | 11 | 103 | 5 | GO:0140105 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | CACNA1C SLC7A11 SLC1A4 SLC1A5 SLC6A6 SLC9A4 SLC9A2 SLC7A3 SLC15A1 KCNJ11 NALF2 | 2.12e-08 | 230 | 103 | 11 | GO:0098739 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1C ABCC4 LILRA2 LILRB2 STEAP4 PANX1 OCA2 LILRB1 SLC1A4 KCNV1 SLC6A6 SLC9A4 SLC9A2 CLCA2 SLC15A1 SCN1A SCN2A KCNJ11 GLRB SCN9A SCN10A NALF2 SLC22A20P | 2.23e-07 | 1374 | 103 | 23 | GO:0006811 |
| GeneOntologyBiologicalProcess | myeloid dendritic cell differentiation | 2.53e-07 | 28 | 103 | 5 | GO:0043011 | |
| GeneOntologyBiologicalProcess | positive regulation of long-term synaptic depression | 5.65e-07 | 14 | 103 | 4 | GO:1900454 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 9.39e-07 | 36 | 103 | 5 | GO:0086010 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1C ABCC4 STEAP4 PANX1 OCA2 SLC1A4 KCNV1 SLC6A6 SLC9A4 SLC9A2 CLCA2 SLC15A1 SCN1A SCN2A KCNJ11 GLRB SCN9A SCN10A NALF2 | 2.34e-06 | 1115 | 103 | 19 | GO:0034220 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1C STEAP4 PANX1 OCA2 SLC1A4 KCNV1 SLC6A6 SLC9A4 SLC9A2 CLCA2 SLC15A1 SCN1A SCN2A KCNJ11 GLRB SCN9A SCN10A NALF2 | 2.64e-06 | 1017 | 103 | 18 | GO:0098660 |
| GeneOntologyBiologicalProcess | myeloid dendritic cell activation | 3.28e-06 | 46 | 103 | 5 | GO:0001773 | |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | DCAF1 IL12A LILRA1 LILRA2 LILRB2 ITGA4 LILRB1 LMBR1L VNN1 ARMC5 RBPJ BTN2A3P PDP2 KLRC1 | 3.59e-06 | 640 | 103 | 14 | GO:1903131 |
| GeneOntologyBiologicalProcess | regulation of long-term synaptic depression | 4.83e-06 | 23 | 103 | 4 | GO:1900452 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR51T1 OR2T29 OR10A2 OR52L1 OR13G1 OR2T5 OR2T10 OR52J3 OR4A16 SCN1A SCN9A SCN10A OR10A5 | 6.59e-06 | 582 | 103 | 13 | GO:0050906 |
| GeneOntologyBiologicalProcess | dendritic cell differentiation | 7.33e-06 | 54 | 103 | 5 | GO:0097028 | |
| GeneOntologyBiologicalProcess | action potential | 7.62e-06 | 201 | 103 | 8 | GO:0001508 | |
| GeneOntologyBiologicalProcess | amino acid import across plasma membrane | 1.05e-05 | 58 | 103 | 5 | GO:0089718 | |
| GeneOntologyBiologicalProcess | walking behavior | 1.24e-05 | 60 | 103 | 5 | GO:0090659 | |
| GeneOntologyBiologicalProcess | detection of stimulus | OR51T1 OR2T29 OR10A2 OR52L1 OR13G1 OR2T5 OR2T10 OR52J3 FAP OR4A16 SCN1A SCN9A SCN10A OR10A5 | 1.41e-05 | 722 | 103 | 14 | GO:0051606 |
| GeneOntologyBiologicalProcess | immune response-inhibiting cell surface receptor signaling pathway | 1.41e-05 | 10 | 103 | 3 | GO:0002767 | |
| GeneOntologyBiologicalProcess | tripeptide transmembrane transport | 1.41e-05 | 10 | 103 | 3 | GO:0035443 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.45e-05 | 62 | 103 | 5 | GO:0086002 | |
| GeneOntologyBiologicalProcess | import into cell | CACNA1C DNER SIRPB1 ITGA4 SLC7A11 LILRB1 SLC1A4 SLC1A5 SLC6A6 SLC9A4 SLC9A2 SLC7A3 VPS33B SLC15A1 LMBR1L KCNJ11 NALF2 | 2.22e-05 | 1074 | 103 | 17 | GO:0098657 |
| GeneOntologyBiologicalProcess | immune response-inhibiting signal transduction | 2.57e-05 | 12 | 103 | 3 | GO:0002765 | |
| GeneOntologyBiologicalProcess | tripeptide transport | 3.34e-05 | 13 | 103 | 3 | GO:0042939 | |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1C LILRA2 LILRB2 STEAP4 PANX1 LILRB1 KCNV1 SLC6A6 SLC9A4 SLC9A2 SCN1A SCN2A KCNJ11 SCN9A SCN10A NALF2 | 3.50e-05 | 1000 | 103 | 16 | GO:0030001 |
| GeneOntologyBiologicalProcess | cell activation | DCAF1 IL12A LILRA1 LILRA2 LILRB2 MFSD2B SIRPB1 ITGA4 SLC7A11 LILRB1 LAT VPS33B LMBR1L VNN1 ARMC5 RBPJ BTN2A3P PDP2 KLRC1 | 3.73e-05 | 1356 | 103 | 19 | GO:0001775 |
| GeneOntologyBiologicalProcess | leukocyte differentiation | DCAF1 IL12A LILRA1 LILRA2 LILRB2 ITGA4 LILRB1 LMBR1L VNN1 ARMC5 RBPJ BTN2A3P PDP2 KLRC1 | 3.75e-05 | 789 | 103 | 14 | GO:0002521 |
| GeneOntologyBiologicalProcess | regulation of dephosphorylation | 4.44e-05 | 128 | 103 | 6 | GO:0035303 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1C LILRA2 LILRB2 STEAP4 PANX1 LILRB1 KCNV1 SLC6A6 SLC9A4 SLC9A2 SLC15A1 SCN1A SCN2A KCNJ11 SCN9A SCN10A NALF2 | 5.66e-05 | 1157 | 103 | 17 | GO:0006812 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR51T1 OR2T29 OR10A2 OR52L1 OR13G1 OR2T5 OR2T10 OR52J3 OR4A16 OR10A5 | 6.09e-05 | 432 | 103 | 10 | GO:0050911 |
| GeneOntologyBiologicalProcess | long-term synaptic depression | 6.83e-05 | 44 | 103 | 4 | GO:0060292 | |
| GeneOntologyBiologicalProcess | modified amino acid transport | 6.83e-05 | 44 | 103 | 4 | GO:0072337 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 7.52e-05 | 87 | 103 | 5 | GO:0086001 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 7.52e-05 | 87 | 103 | 5 | GO:0150104 | |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | DCAF1 IL12A LILRB2 ITGA4 LMBR1L VNN1 ARMC5 RBPJ BTN2A3P PDP2 KLRC1 | 7.73e-05 | 537 | 103 | 11 | GO:0030098 |
| GeneOntologyBiologicalProcess | oligopeptide transmembrane transport | 7.82e-05 | 17 | 103 | 3 | GO:0035672 | |
| GeneOntologyBiologicalProcess | vascular transport | 7.94e-05 | 88 | 103 | 5 | GO:0010232 | |
| GeneOntologyBiologicalProcess | sensory perception | USP53 OR51T1 OR2T29 MINAR2 OR10A2 OR52L1 OR13G1 OR2T5 OR2T10 OR52J3 OR4A16 SCN1A GLRB SCN9A SCN10A OR10A5 | 8.00e-05 | 1072 | 103 | 16 | GO:0007600 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 8.38e-05 | 208 | 103 | 7 | GO:0035725 | |
| GeneOntologyBiologicalProcess | B cell homeostasis | 9.64e-05 | 48 | 103 | 4 | GO:0001782 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 1.03e-04 | 93 | 103 | 5 | GO:0086003 | |
| GeneOntologyBiologicalProcess | hemopoiesis | DCAF1 IL12A LILRA1 LILRA2 LILRB2 SIRPB1 ITGA4 LILRB1 SLC1A5 VPS33B LMBR1L VNN1 ARMC5 RBPJ BTN2A3P PDP2 KLRC1 | 1.12e-04 | 1223 | 103 | 17 | GO:0030097 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR51T1 OR2T29 OR10A2 OR52L1 OR13G1 OR2T5 OR2T10 OR52J3 OR4A16 OR10A5 | 1.12e-04 | 465 | 103 | 10 | GO:0007608 |
| GeneOntologyBiologicalProcess | adult walking behavior | 1.13e-04 | 50 | 103 | 4 | GO:0007628 | |
| GeneOntologyBiologicalProcess | leukocyte homeostasis | 1.19e-04 | 153 | 103 | 6 | GO:0001776 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 1.19e-04 | 153 | 103 | 6 | GO:0098656 | |
| GeneOntologyBiologicalProcess | behavior | CACNA1C LILRA1 MINAR2 LILRA2 LILRB2 SLC7A11 PIAS1 LILRB1 UCHL3 SCN1A SCN2A GLRB SCN9A SCN10A | 1.37e-04 | 891 | 103 | 14 | GO:0007610 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR51T1 OR2T29 OR10A2 OR52L1 OR13G1 OR2T5 OR2T10 OR52J3 OR4A16 OR10A5 | 1.58e-04 | 485 | 103 | 10 | GO:0050907 |
| GeneOntologyBiologicalProcess | lymphocyte homeostasis | 1.75e-04 | 104 | 103 | 5 | GO:0002260 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 1.93e-04 | 167 | 103 | 6 | GO:1903825 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1C STEAP4 PANX1 KCNV1 SLC6A6 SLC9A4 SLC9A2 SLC15A1 SCN1A SCN2A KCNJ11 SCN9A SCN10A NALF2 | 1.95e-04 | 922 | 103 | 14 | GO:0098662 |
| GeneOntologyBiologicalProcess | oligopeptide transport | 1.99e-04 | 23 | 103 | 3 | GO:0006857 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 2.16e-04 | 59 | 103 | 4 | GO:0045671 | |
| GeneOntologyBiologicalProcess | neutral amino acid transport | 2.31e-04 | 60 | 103 | 4 | GO:0015804 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1C STEAP4 PANX1 KCNV1 SLC6A6 SLC9A4 SLC9A2 SLC15A1 SCN1A SCN2A KCNJ11 SCN9A SCN10A NALF2 | 2.44e-04 | 942 | 103 | 14 | GO:0098655 |
| GeneOntologyBiologicalProcess | Fc receptor mediated inhibitory signaling pathway | 2.45e-04 | 5 | 103 | 2 | GO:0002774 | |
| GeneOntologyBiologicalProcess | oligopeptide import across plasma membrane | 2.45e-04 | 5 | 103 | 2 | GO:0140205 | |
| GeneOntologyBiologicalProcess | dipeptide import across plasma membrane | 2.45e-04 | 5 | 103 | 2 | GO:0140206 | |
| GeneOntologyBiologicalProcess | organic anion transport | ABCC4 SLC16A9 PANX1 SLC7A11 SLC1A4 SLC1A5 SLC6A6 SLC7A3 SLC35D3 SLC22A20P | 2.55e-04 | 515 | 103 | 10 | GO:0015711 |
| GeneOntologyBiologicalProcess | leukocyte activation | DCAF1 IL12A LILRA1 LILRA2 LILRB2 SIRPB1 ITGA4 LILRB1 LAT LMBR1L VNN1 ARMC5 RBPJ BTN2A3P PDP2 KLRC1 | 2.55e-04 | 1186 | 103 | 16 | GO:0045321 |
| GeneOntologyBiologicalProcess | positive regulation of dephosphorylation | 2.62e-04 | 62 | 103 | 4 | GO:0035306 | |
| GeneOntologyBiologicalProcess | cognition | CACNA1C LILRA1 LILRA2 LILRB2 SLC7A11 PIAS1 LILRB1 SLC1A4 SCN2A | 2.70e-04 | 423 | 103 | 9 | GO:0050890 |
| GeneOntologyBiologicalProcess | neuronal action potential | 2.79e-04 | 63 | 103 | 4 | GO:0019228 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR51T1 OR2T29 OR10A2 OR52L1 OR13G1 OR2T5 OR2T10 OR52J3 OR4A16 OR10A5 | 2.93e-04 | 524 | 103 | 10 | GO:0009593 |
| GeneOntologyBiologicalProcess | circulatory system process | CACNA1C ABCC4 ITGA4 SLC1A4 SLC1A5 DOCK5 SLC6A6 SLC7A3 SCN1A SCN2A SCN9A SCN10A | 2.94e-04 | 733 | 103 | 12 | GO:0003013 |
| GeneOntologyBiologicalProcess | protein dephosphorylation | 3.01e-04 | 256 | 103 | 7 | GO:0006470 | |
| GeneOntologyBiologicalProcess | sulfur compound transport | 3.14e-04 | 65 | 103 | 4 | GO:0072348 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 3.15e-04 | 183 | 103 | 6 | GO:0006820 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | 3.32e-04 | 344 | 103 | 8 | GO:0003018 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 3.41e-04 | 120 | 103 | 5 | GO:0003333 | |
| GeneOntologyBiologicalProcess | lymphocyte activation | DCAF1 IL12A LILRB2 SIRPB1 ITGA4 LILRB1 LAT LMBR1L VNN1 ARMC5 RBPJ BTN2A3P PDP2 KLRC1 | 3.49e-04 | 976 | 103 | 14 | GO:0046649 |
| GeneOntologyBiologicalProcess | regulation of long-term synaptic potentiation | 3.53e-04 | 67 | 103 | 4 | GO:1900271 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 3.54e-04 | 121 | 103 | 5 | GO:0051899 | |
| GeneOntologyBiologicalProcess | L-aspartate import across plasma membrane | 3.66e-04 | 6 | 103 | 2 | GO:0140009 | |
| GeneOntologyBiologicalProcess | L-cystine transport | 3.66e-04 | 6 | 103 | 2 | GO:0015811 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR51T1 OR2T29 OR10A2 OR52L1 OR13G1 OR2T5 OR2T10 OR52J3 OR4A16 OR10A5 | 4.11e-04 | 547 | 103 | 10 | GO:0007606 |
| GeneOntologyBiologicalProcess | amino acid transport | 4.42e-04 | 195 | 103 | 6 | GO:0006865 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 4.42e-04 | 127 | 103 | 5 | GO:0070252 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 4.62e-04 | 275 | 103 | 7 | GO:0006814 | |
| GeneOntologyBiologicalProcess | regulation of presynaptic membrane potential | 5.40e-04 | 32 | 103 | 3 | GO:0099505 | |
| GeneOntologyBiologicalProcess | learning or memory | 5.67e-04 | 373 | 103 | 8 | GO:0007611 | |
| GeneOntologyBiologicalProcess | T cell differentiation | 6.62e-04 | 382 | 103 | 8 | GO:0030217 | |
| GeneOntologyBiologicalProcess | glutathione transmembrane transport | 6.78e-04 | 8 | 103 | 2 | GO:0034775 | |
| GeneOntologyBiologicalProcess | dipeptide transport | 6.78e-04 | 8 | 103 | 2 | GO:0042938 | |
| GeneOntologyBiologicalProcess | dipeptide transmembrane transport | 6.78e-04 | 8 | 103 | 2 | GO:0035442 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission | 6.93e-04 | 80 | 103 | 4 | GO:0050805 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 7.35e-04 | 142 | 103 | 5 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 7.35e-04 | 142 | 103 | 5 | GO:0098659 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion | 7.45e-04 | 389 | 103 | 8 | GO:0022409 | |
| GeneOntologyBiologicalProcess | T cell activation | IL12A LILRB2 SIRPB1 LILRB1 LAT LMBR1L VNN1 ARMC5 BTN2A3P PDP2 KLRC1 | 7.55e-04 | 701 | 103 | 11 | GO:0042110 |
| GeneOntologyBiologicalProcess | organic cation transport | 8.07e-04 | 145 | 103 | 5 | GO:0015695 | |
| GeneOntologyBiologicalProcess | L-serine transport | 8.69e-04 | 9 | 103 | 2 | GO:0015825 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 8.71e-04 | 85 | 103 | 4 | GO:0002762 | |
| GeneOntologyBiologicalProcess | L-alpha-amino acid transmembrane transport | 9.50e-04 | 87 | 103 | 4 | GO:1902475 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 1.03e-03 | 153 | 103 | 5 | GO:0030048 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte cell-cell adhesion | 1.07e-03 | 317 | 103 | 7 | GO:1903039 | |
| GeneOntologyBiologicalProcess | glutamine transport | 1.08e-03 | 10 | 103 | 2 | GO:0006868 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception of pain | 1.29e-03 | 43 | 103 | 3 | GO:0062149 | |
| GeneOntologyBiologicalProcess | glutathione transport | 1.32e-03 | 11 | 103 | 2 | GO:0034635 | |
| GeneOntologyBiologicalProcess | L-aspartate transmembrane transport | 1.32e-03 | 11 | 103 | 2 | GO:0070778 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell mediated cytotoxicity | 1.32e-03 | 11 | 103 | 2 | GO:0001915 | |
| GeneOntologyCellularComponent | Fc-epsilon receptor I complex | 7.43e-08 | 9 | 105 | 4 | GO:0032998 | |
| GeneOntologyCellularComponent | Fc receptor complex | 2.88e-07 | 12 | 105 | 4 | GO:0032997 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.36e-06 | 17 | 105 | 4 | GO:0001518 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1C LILRA1 LILRA2 LILRB2 ITGA4 ACVR1C LILRB1 KCNV1 SLC6A6 SCN1A SCN2A KCNJ11 GLRB SCN9A SCN10A | 8.74e-06 | 785 | 105 | 15 | GO:0098797 |
| GeneOntologyCellularComponent | cell surface | BOC CACNA1C IL12A LILRA1 ABCC4 LILRA2 LILRB2 SIRPB1 ITGA4 ACVR1C SLC7A11 LILRB1 SLC1A4 FAP GYPB GLRB BTN2A3P KLRC1 | 9.88e-06 | 1111 | 105 | 18 | GO:0009986 |
| GeneOntologyCellularComponent | sodium channel complex | 1.30e-05 | 29 | 105 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | cation channel complex | 1.86e-04 | 235 | 105 | 7 | GO:0034703 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule membrane | 2.52e-04 | 61 | 105 | 4 | GO:0101003 | |
| GeneOntologyCellularComponent | secretory granule membrane | 2.57e-04 | 329 | 105 | 8 | GO:0030667 | |
| GeneOntologyCellularComponent | external side of plasma membrane | LILRA1 ABCC4 LILRA2 LILRB2 ITGA4 LILRB1 GYPB GLRB BTN2A3P KLRC1 | 2.86e-04 | 519 | 105 | 10 | GO:0009897 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 6.44e-04 | 378 | 105 | 8 | GO:0034702 | |
| GeneOntologyCellularComponent | T-tubule | 6.76e-04 | 79 | 105 | 4 | GO:0030315 | |
| GeneOntologyCellularComponent | anchoring junction | USP53 PANX1 ITGA4 FOCAD DOCK5 FAP CLDN11 LAT CLCA2 SCN1A SCN2A KCNJ11 ARMC5 | 1.21e-03 | 976 | 105 | 13 | GO:0070161 |
| GeneOntologyCellularComponent | membrane protein complex | CACNA1C LILRA1 LILRA2 LILRB2 ITGA4 ACVR1C LILRB1 KCNV1 SLC6A6 VPS33B GYPB SCN1A SCN2A KCNJ11 GLRB SCN9A SCN10A | 1.25e-03 | 1498 | 105 | 17 | GO:0098796 |
| GeneOntologyCellularComponent | side of membrane | LILRA1 ABCC4 LILRA2 LILRB2 ITGA4 LILRB1 VNN1 GYPB GLRB BTN2A3P LY6L KLRC1 | 1.47e-03 | 875 | 105 | 12 | GO:0098552 |
| GeneOntologyCellularComponent | secretory granule | ABCC4 LILRA3 LILRB2 UBR4 PRAMEF12 SIRPB1 ENPP4 HUWE1 SLC9A4 VPS33B VNN1 KCNJ11 BACE2 | 1.70e-03 | 1014 | 105 | 13 | GO:0030141 |
| GeneOntologyCellularComponent | ficolin-1-rich granule | 2.43e-03 | 185 | 105 | 5 | GO:0101002 | |
| GeneOntologyCellularComponent | melanosome | 2.54e-03 | 113 | 105 | 4 | GO:0042470 | |
| GeneOntologyCellularComponent | pigment granule | 2.54e-03 | 113 | 105 | 4 | GO:0048770 | |
| GeneOntologyCellularComponent | basal part of cell | 2.99e-03 | 378 | 105 | 7 | GO:0045178 | |
| GeneOntologyCellularComponent | secretory vesicle | ABCC4 LILRA3 LILRB2 UBR4 PRAMEF12 SIRPB1 ENPP4 HUWE1 SLC9A4 VPS33B VNN1 KCNJ11 SLC35D3 BACE2 | 3.78e-03 | 1246 | 105 | 14 | GO:0099503 |
| HumanPheno | Photosensitive myoclonic seizure | 7.31e-06 | 8 | 27 | 3 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 7.31e-06 | 8 | 27 | 3 | HP:0200048 | |
| HumanPheno | Limited neck range of motion | 2.13e-05 | 11 | 27 | 3 | HP:0000466 | |
| HumanPheno | Obsessive-compulsive trait | 2.31e-05 | 33 | 27 | 4 | HP:0008770 | |
| HumanPheno | Epilepsia partialis continua | 2.83e-05 | 12 | 27 | 3 | HP:0012847 | |
| HumanPheno | Limitation of neck motion | 3.29e-05 | 36 | 27 | 4 | HP:0005986 | |
| HumanPheno | Abnormal neck physiology | 3.29e-05 | 36 | 27 | 4 | HP:0025669 | |
| HumanPheno | Generalized cerebral atrophy/hypoplasia | 3.67e-05 | 13 | 27 | 3 | HP:0007058 | |
| HumanPheno | Facial tics | 5.79e-05 | 15 | 27 | 3 | HP:0011468 | |
| HumanPheno | Photosensitive tonic-clonic seizure | 5.79e-05 | 15 | 27 | 3 | HP:0007207 | |
| HumanPheno | Dysgenesis of the hippocampus | 7.10e-05 | 16 | 27 | 3 | HP:0025101 | |
| HumanPheno | Complex febrile seizure | 7.10e-05 | 16 | 27 | 3 | HP:0011172 | |
| HumanPheno | Abnormal hepatocyte morphology | 8.09e-05 | 3 | 27 | 2 | HP:0034713 | |
| HumanPheno | Focal motor status epilepticus | 8.60e-05 | 17 | 27 | 3 | HP:0032663 | |
| HumanPheno | Atypical absence status epilepticus | 8.60e-05 | 17 | 27 | 3 | HP:0011151 | |
| HumanPheno | Visually-induced seizure | 1.03e-04 | 18 | 27 | 3 | HP:0020216 | |
| HumanPheno | Generalized non-convulsive status epilepticus without coma | 1.03e-04 | 18 | 27 | 3 | HP:0032860 | |
| HumanPheno | Non-convulsive status epilepticus without coma | 1.43e-04 | 20 | 27 | 3 | HP:0032671 | |
| HumanPheno | Drooling | 1.55e-04 | 161 | 27 | 6 | HP:0002307 | |
| HumanPheno | Talipes valgus | 1.66e-04 | 21 | 27 | 3 | HP:0004684 | |
| HumanPheno | Pes valgus | 1.91e-04 | 56 | 27 | 4 | HP:0008081 | |
| HumanPheno | Reflex seizure | 1.91e-04 | 22 | 27 | 3 | HP:0020207 | |
| HumanPheno | Excessive salivation | 2.09e-04 | 170 | 27 | 6 | HP:0003781 | |
| HumanPheno | Tibial torsion | 2.19e-04 | 23 | 27 | 3 | HP:0100694 | |
| HumanPheno | Dermatological manifestations of systemic disorders | 2.58e-04 | 435 | 27 | 9 | HP:0001005 | |
| HumanPheno | Allodynia | 2.68e-04 | 5 | 27 | 2 | HP:0012533 | |
| HumanPheno | Focal hemiclonic seizure | 2.83e-04 | 25 | 27 | 3 | HP:0006813 | |
| HumanPheno | Limited knee extension | 3.57e-04 | 27 | 27 | 3 | HP:0003066 | |
| HumanPheno | Status epilepticus without prominent motor symptoms | 3.57e-04 | 27 | 27 | 3 | HP:0031475 | |
| HumanPheno | Focal aware seizure | 3.98e-04 | 28 | 27 | 3 | HP:0002349 | |
| HumanPheno | Poor fine motor coordination | 4.28e-04 | 69 | 27 | 4 | HP:0007010 | |
| HumanPheno | Status epilepticus with prominent motor symptoms | 4.43e-04 | 29 | 27 | 3 | HP:0032658 | |
| HumanPheno | Progressive gait ataxia | 4.90e-04 | 30 | 27 | 3 | HP:0007240 | |
| HumanPheno | Progressive ataxia | 4.90e-04 | 30 | 27 | 3 | HP:0001329 | |
| HumanPheno | Cogwheel rigidity | 5.95e-04 | 32 | 27 | 3 | HP:0002396 | |
| HumanPheno | Generalized clonic seizure | 7.12e-04 | 34 | 27 | 3 | HP:0011169 | |
| HumanPheno | Abnormality of temperature sensation | 7.12e-04 | 34 | 27 | 3 | HP:0100772 | |
| HumanPheno | Impaired temperature sensation | 7.12e-04 | 34 | 27 | 3 | HP:0010829 | |
| HumanPheno | Calcaneovalgus deformity | 7.12e-04 | 34 | 27 | 3 | HP:0001848 | |
| HumanPheno | Abnormality of salivation | 7.40e-04 | 215 | 27 | 6 | HP:0100755 | |
| HumanPheno | Deformed tarsal bones | 7.76e-04 | 35 | 27 | 3 | HP:0008119 | |
| HumanPheno | Limitation of knee mobility | 7.76e-04 | 35 | 27 | 3 | HP:0010501 | |
| HumanPheno | Disturbance of facial expression | 8.44e-04 | 36 | 27 | 3 | HP:0005324 | |
| HumanPheno | Poor motor coordination | 9.46e-04 | 85 | 27 | 4 | HP:0002275 | |
| HumanPheno | Pruritus | 9.60e-04 | 149 | 27 | 5 | HP:0000989 | |
| MousePheno | decreased length of allograft survival | 1.23e-07 | 9 | 80 | 4 | MP:0004752 | |
| MousePheno | abnormal visual cortex morphology | 1.72e-06 | 16 | 80 | 4 | MP:0000805 | |
| MousePheno | abnormal T-helper 2 physiology | 2.20e-06 | 67 | 80 | 6 | MP:0005466 | |
| MousePheno | abnormal occipital lobe morphology | 2.86e-06 | 18 | 80 | 4 | MP:0000804 | |
| MousePheno | abnormal dendritic cell differentiation | 4.49e-06 | 20 | 80 | 4 | MP:0008115 | |
| MousePheno | increased B-1 B cell number | 2.13e-05 | 59 | 80 | 5 | MP:0004977 | |
| MousePheno | abnormal CD4-positive, alpha-beta T cell physiology | 4.33e-05 | 165 | 80 | 7 | MP:0005463 | |
| MousePheno | abnormal T cell physiology | IL12A LILRA1 LILRA2 LILRB2 PANX1 ST8SIA1 ITGA4 LILRB1 SLC1A5 LAT LMBR1L BTN2A3P | 1.13e-04 | 584 | 80 | 12 | MP:0002444 |
| Domain | ARM-type_fold | DCAF1 ZYG11A IPO8 UBR4 HUWE1 CWC22 FOCAD DOCK5 PELP1 ARMC5 WDFY3 PPP6R2 PPP6R3 | 5.11e-08 | 339 | 104 | 13 | IPR016024 |
| Domain | Na_channel_asu | 1.86e-07 | 10 | 104 | 4 | IPR001696 | |
| Domain | Na_trans_assoc | 1.86e-07 | 10 | 104 | 4 | IPR010526 | |
| Domain | Na_trans_assoc | 1.86e-07 | 10 | 104 | 4 | PF06512 | |
| Domain | Channel_four-helix_dom | 7.43e-07 | 57 | 104 | 6 | IPR027359 | |
| Domain | - | 7.43e-07 | 57 | 104 | 6 | 1.20.120.350 | |
| Domain | Na_trans_cytopl | 3.31e-06 | 6 | 104 | 3 | PF11933 | |
| Domain | A1B_glyco/leuk_Ig-like_rcpt | 3.31e-06 | 6 | 104 | 3 | IPR016332 | |
| Domain | Na_trans_cytopl | 3.31e-06 | 6 | 104 | 3 | IPR024583 | |
| Domain | ARM-like | 2.00e-05 | 270 | 104 | 9 | IPR011989 | |
| Domain | Na/H_exchanger_2 | 3.07e-05 | 2 | 104 | 2 | IPR001953 | |
| Domain | Ion_trans_dom | 4.23e-05 | 114 | 104 | 6 | IPR005821 | |
| Domain | Ion_trans | 4.23e-05 | 114 | 104 | 6 | PF00520 | |
| Domain | Olfact_rcpt | OR51T1 OR2T29 OR10A2 OR52L1 OR13G1 OR2T5 OR2T10 OR52J3 OR4A16 OR10A5 | 6.83e-05 | 393 | 104 | 10 | IPR000725 |
| Domain | NHE_CaM-bd | 9.18e-05 | 3 | 104 | 2 | IPR032103 | |
| Domain | SAPS | 9.18e-05 | 3 | 104 | 2 | IPR007587 | |
| Domain | NEXCaM_BD | 9.18e-05 | 3 | 104 | 2 | PF16644 | |
| Domain | SAPS | 9.18e-05 | 3 | 104 | 2 | PF04499 | |
| Domain | MFS_dom | 1.04e-04 | 134 | 104 | 6 | IPR020846 | |
| Domain | PINIT | 1.83e-04 | 4 | 104 | 2 | IPR023321 | |
| Domain | PINIT | 1.83e-04 | 4 | 104 | 2 | PS51466 | |
| Domain | PINIT | 1.83e-04 | 4 | 104 | 2 | PF14324 | |
| Domain | MFS | 3.44e-04 | 108 | 104 | 5 | PS50850 | |
| Domain | Na-dicarboxylate_symporter | 6.33e-04 | 7 | 104 | 2 | IPR001991 | |
| Domain | zf-MIZ | 6.33e-04 | 7 | 104 | 2 | PF02891 | |
| Domain | NA_DICARBOXYL_SYMP_1 | 6.33e-04 | 7 | 104 | 2 | PS00713 | |
| Domain | NA_DICARBOXYL_SYMP_2 | 6.33e-04 | 7 | 104 | 2 | PS00714 | |
| Domain | Na-dicarboxylate_symporter_CS | 6.33e-04 | 7 | 104 | 2 | IPR018107 | |
| Domain | ZF_SP_RING | 6.33e-04 | 7 | 104 | 2 | PS51044 | |
| Domain | SDF | 6.33e-04 | 7 | 104 | 2 | PF00375 | |
| Domain | - | 6.33e-04 | 7 | 104 | 2 | 1.10.3860.10 | |
| Domain | ig | 6.81e-04 | 190 | 104 | 6 | PF00047 | |
| Domain | Immunoglobulin | 6.81e-04 | 190 | 104 | 6 | IPR013151 | |
| Domain | Ig_2 | 7.35e-04 | 73 | 104 | 4 | PF13895 | |
| Domain | Znf_MIZ | 8.41e-04 | 8 | 104 | 2 | IPR004181 | |
| Domain | NaH_exchanger | 1.08e-03 | 9 | 104 | 2 | IPR004709 | |
| Domain | GPCR_Rhodpsn_7TM | OR51T1 OR2T29 OR10A2 OR52L1 OR13G1 OR2T5 OR2T10 PTGFR OR52J3 OR4A16 OR10A5 | 1.26e-03 | 670 | 104 | 11 | IPR017452 |
| Domain | 7tm_1 | OR51T1 OR2T29 OR10A2 OR52L1 OR13G1 OR2T5 OR2T10 PTGFR OR52J3 OR4A16 OR10A5 | 1.37e-03 | 677 | 104 | 11 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR51T1 OR2T29 OR10A2 OR52L1 OR13G1 OR2T5 OR2T10 PTGFR OR52J3 OR4A16 OR10A5 | 1.51e-03 | 685 | 104 | 11 | PS00237 |
| Domain | IQ_motif_EF-hand-BS | 1.61e-03 | 90 | 104 | 4 | IPR000048 | |
| Domain | G_PROTEIN_RECEP_F1_2 | OR51T1 OR2T29 OR10A2 OR52L1 OR13G1 OR2T5 OR2T10 PTGFR OR52J3 OR4A16 OR10A5 | 1.61e-03 | 691 | 104 | 11 | PS50262 |
| Domain | GPCR_Rhodpsn | OR51T1 OR2T29 OR10A2 OR52L1 OR13G1 OR2T5 OR2T10 PTGFR OR52J3 OR4A16 OR10A5 | 1.63e-03 | 692 | 104 | 11 | IPR000276 |
| Domain | Cation/H_exchanger_CPA1 | 1.63e-03 | 11 | 104 | 2 | IPR018422 | |
| Domain | IG_LIKE | BOC LILRA1 LILRA3 LILRA2 LILRB2 SIRPB1 LILRB1 BTN2A3P AMIGO2 | 1.68e-03 | 491 | 104 | 9 | PS50835 |
| Domain | IQ | 1.81e-03 | 93 | 104 | 4 | PS50096 | |
| Domain | Ig-like_fold | BOC LILRA1 LILRA3 LILRA2 LILRB2 SIRPB1 LILRB1 TGM5 RBPJ BTN2A3P AMIGO2 | 1.91e-03 | 706 | 104 | 11 | IPR013783 |
| Domain | Ig-like_dom | BOC LILRA1 LILRA3 LILRA2 LILRB2 SIRPB1 LILRB1 BTN2A3P AMIGO2 | 1.98e-03 | 503 | 104 | 9 | IPR007110 |
| Domain | AA_permease_2 | 2.30e-03 | 13 | 104 | 2 | PF13520 | |
| Domain | AA/rel_permease1 | 2.30e-03 | 13 | 104 | 2 | IPR002293 | |
| Domain | IG | 2.44e-03 | 421 | 104 | 8 | SM00409 | |
| Domain | Ig_sub | 2.44e-03 | 421 | 104 | 8 | IPR003599 | |
| Domain | Na_H_Exchanger | 2.68e-03 | 14 | 104 | 2 | PF00999 | |
| Domain | Cation/H_exchanger | 2.68e-03 | 14 | 104 | 2 | IPR006153 | |
| Domain | Glyco_trans_29 | 5.47e-03 | 20 | 104 | 2 | IPR001675 | |
| Domain | Glyco_transf_29 | 5.47e-03 | 20 | 104 | 2 | PF00777 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 2.46e-07 | 108 | 84 | 8 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 2.64e-07 | 109 | 84 | 8 | MM15074 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 1.18e-06 | 32 | 84 | 5 | MM14957 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 1.18e-06 | 32 | 84 | 5 | M27455 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 1.39e-06 | 33 | 84 | 5 | M188 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR51T1 OR2T29 OR10A2 OR52L1 OR13G1 OR2T5 OR2T10 OR52J3 CLCA2 OR4A16 OR10A5 | 1.87e-05 | 389 | 84 | 11 | M14091 |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 3.26e-05 | 31 | 84 | 4 | M877 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 8.48e-05 | 238 | 84 | 8 | MM15076 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 1.16e-04 | 249 | 84 | 8 | M5988 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.24e-04 | 130 | 84 | 6 | M27454 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 1.37e-04 | 190 | 84 | 7 | M8240 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR51T1 OR2T29 OR10A2 OR52L1 OR13G1 OR2T5 OR2T10 OR52J3 OR4A16 OR10A5 | 1.80e-04 | 417 | 84 | 10 | M4072 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR51T1 OR2T29 OR10A2 OR52L1 OR13G1 OR2T5 OR2T10 OR52J3 OR4A16 SCN2A SCN9A OR10A5 | 3.69e-04 | 636 | 84 | 12 | M41834 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCC4 STEAP4 SLC7A11 SLC1A4 SLC1A5 SLC6A6 SLC9A4 SLC9A2 SLC7A3 CLCA2 SLC15A1 KCNJ11 | 6.79e-04 | 681 | 84 | 12 | MM14985 |
| Pathway | WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A | 7.23e-04 | 7 | 84 | 2 | M42540 | |
| Pathway | WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS | 7.23e-04 | 7 | 84 | 2 | M45522 | |
| Pathway | WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY | 8.94e-04 | 32 | 84 | 3 | M42560 | |
| Pubmed | 1.33e-11 | 8 | 106 | 5 | 9548455 | ||
| Pubmed | 8.15e-11 | 4 | 106 | 4 | 21559424 | ||
| Pubmed | HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding. | 8.15e-11 | 4 | 106 | 4 | 21270408 | |
| Pubmed | 1.09e-10 | 11 | 106 | 5 | 20145200 | ||
| Pubmed | Regulation of cytotoxic T lymphocyte triggering by PIR-B on dendritic cells. | 4.07e-10 | 5 | 106 | 4 | 18787130 | |
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 34242819 | ||
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 20976309 | ||
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 20881122 | ||
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 27443384 | ||
| Pubmed | The inhibitory receptor PIR-B negatively regulates neutrophil and macrophage integrin signaling. | 4.07e-10 | 5 | 106 | 4 | 15494528 | |
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 19684158 | ||
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 37146940 | ||
| Pubmed | PirB functions as an intrinsic suppressor in hippocampal neural stem cells. | 4.07e-10 | 5 | 106 | 4 | 34120891 | |
| Pubmed | PirB regulates a structural substrate for cortical plasticity. | 4.07e-10 | 5 | 106 | 4 | 24302763 | |
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 23927735 | ||
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 34437845 | ||
| Pubmed | Paired immunoglobulin-like receptor B is an entry receptor for mammalian orthoreovirus. | 4.07e-10 | 5 | 106 | 4 | 37147336 | |
| Pubmed | Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity. | 4.07e-10 | 5 | 106 | 4 | 33653799 | |
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 21087927 | ||
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 20398663 | ||
| Pubmed | Structure and flexibility of the extracellular region of the PirB receptor. | 4.07e-10 | 5 | 106 | 4 | 30674550 | |
| Pubmed | Inhibitory receptor paired Ig-like receptor B is exploited by Staphylococcus aureus for virulence. | 4.07e-10 | 5 | 106 | 4 | 23152562 | |
| Pubmed | Regulation of plasmacytoid dendritic cell responses by PIR-B. | 4.07e-10 | 5 | 106 | 4 | 22948046 | |
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 9054430 | ||
| Pubmed | Paternal monoallelic expression of the paired immunoglobulin-like receptors PIR-A and PIR-B. | 4.07e-10 | 5 | 106 | 4 | 10359805 | |
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 27324131 | ||
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 10586026 | ||
| Pubmed | Paired immunoglobulin-like receptor B regulates platelet activation. | 4.07e-10 | 5 | 106 | 4 | 25075127 | |
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 9550322 | ||
| Pubmed | Expression of PirB protein in intact and injured optic nerve and retina of mice. | 4.07e-10 | 5 | 106 | 4 | 22102155 | |
| Pubmed | Paired immunoglobulin-like receptors and their MHC class I recognition. | 4.07e-10 | 5 | 106 | 4 | 16011512 | |
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 23258232 | ||
| Pubmed | Mast cell regulation via paired immunoglobulin-like receptor PIR-B. | 4.07e-10 | 5 | 106 | 4 | 12403357 | |
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 28664612 | ||
| Pubmed | HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor. | 1.22e-09 | 6 | 106 | 4 | 12207326 | |
| Pubmed | Cell-Autonomous Regulation of Dendritic Spine Density by PirB. | 1.22e-09 | 6 | 106 | 4 | 27752542 | |
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 9824165 | ||
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 38383888 | ||
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 39095838 | ||
| Pubmed | PirB is a functional receptor for myelin inhibitors of axonal regeneration. | 1.22e-09 | 6 | 106 | 4 | 18988857 | |
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 27402837 | ||
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 28594961 | ||
| Pubmed | The p75 receptor mediates axon growth inhibition through an association with PIR-B. | 1.22e-09 | 6 | 106 | 4 | 21881600 | |
| Pubmed | Impaired dendritic cell maturation and increased T(H)2 responses in PIR-B(-/-) mice. | 1.22e-09 | 6 | 106 | 4 | 12021780 | |
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 15146181 | ||
| Pubmed | PIR-B-deficient mice are susceptible to Salmonella infection. | 1.22e-09 | 6 | 106 | 4 | 18768880 | |
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 29482582 | ||
| Pubmed | LILRB2/PirB mediates macrophage recruitment in fibrogenesis of nonalcoholic steatohepatitis. | 1.22e-09 | 6 | 106 | 4 | 37481670 | |
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 31727773 | ||
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 25320232 | ||
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 30787106 | ||
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 9079806 | ||
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 21636572 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 1.22e-09 | 6 | 106 | 4 | 23652591 | |
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 24040397 | ||
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 24212998 | ||
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 30068593 | ||
| Pubmed | 2.83e-09 | 7 | 106 | 4 | 36510132 | ||
| Pubmed | 2.83e-09 | 7 | 106 | 4 | 19687229 | ||
| Pubmed | 2.83e-09 | 7 | 106 | 4 | 17998301 | ||
| Pubmed | PirB restricts ocular-dominance plasticity in visual cortex. | 2.83e-09 | 7 | 106 | 4 | 16917027 | |
| Pubmed | 2.83e-09 | 7 | 106 | 4 | 35321392 | ||
| Pubmed | 2.83e-09 | 7 | 106 | 4 | 20844138 | ||
| Pubmed | Paired Ig-like receptors bind to bacteria and shape TLR-mediated cytokine production. | 2.83e-09 | 7 | 106 | 4 | 17371981 | |
| Pubmed | Transcriptional activation of the Pirb gene in B cells by PU.1 and Runx3. | 2.83e-09 | 7 | 106 | 4 | 21555536 | |
| Pubmed | Alternative mRNA splicing creates transcripts encoding soluble proteins from most LILR genes. | 2.83e-09 | 7 | 106 | 4 | 19658091 | |
| Pubmed | The Nogo-B-PirB axis controls macrophage-mediated vascular remodeling. | 2.83e-09 | 7 | 106 | 4 | 24278366 | |
| Pubmed | A dual activation and inhibition role for the paired immunoglobulin-like receptor B in eosinophils. | 2.83e-09 | 7 | 106 | 4 | 18316626 | |
| Pubmed | 2.83e-09 | 7 | 106 | 4 | 27897222 | ||
| Pubmed | Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development. | 5.65e-09 | 8 | 106 | 4 | 22660330 | |
| Pubmed | 5.65e-09 | 8 | 106 | 4 | 21376641 | ||
| Pubmed | 5.65e-09 | 8 | 106 | 4 | 18209065 | ||
| Pubmed | NogoR1 and PirB signaling stimulates neural stem cell survival and proliferation. | 5.65e-09 | 8 | 106 | 4 | 24449409 | |
| Pubmed | 5.65e-09 | 8 | 106 | 4 | 19255189 | ||
| Pubmed | Genomic structures and chromosomal location of p91, a novel murine regulatory receptor family. | 5.65e-09 | 8 | 106 | 4 | 9538215 | |
| Pubmed | VCAM1 confers innate immune tolerance on haematopoietic and leukaemic stem cells. | 5.65e-09 | 8 | 106 | 4 | 35210567 | |
| Pubmed | Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation. | 1.01e-08 | 9 | 106 | 4 | 17420263 | |
| Pubmed | 1.01e-08 | 9 | 106 | 4 | 16382098 | ||
| Pubmed | PIRs mediate innate myeloid cell memory to nonself MHC molecules. | 1.69e-08 | 10 | 106 | 4 | 32381589 | |
| Pubmed | Inhibitory immunoglobulin-like receptors LILRB and PIR-B negatively regulate osteoclast development. | 1.69e-08 | 10 | 106 | 4 | 18802077 | |
| Pubmed | Myelin suppresses axon regeneration by PIR-B/SHP-mediated inhibition of Trk activity. | 2.65e-08 | 11 | 106 | 4 | 21364532 | |
| Pubmed | 2.65e-08 | 11 | 106 | 4 | 24738827 | ||
| Pubmed | 2.65e-08 | 11 | 106 | 4 | 24052308 | ||
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 14662864 | ||
| Pubmed | Amino acid transport across mammalian intestinal and renal epithelia. | 3.81e-08 | 31 | 106 | 5 | 18195088 | |
| Pubmed | 3.96e-08 | 12 | 106 | 4 | 22445338 | ||
| Pubmed | Constitutive tyrosine phosphorylation of the inhibitory paired Ig-like receptor PIR-B. | 3.96e-08 | 12 | 106 | 4 | 10611342 | |
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 15123669 | ||
| Pubmed | A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. | 1.08e-07 | 15 | 106 | 4 | 9144225 | |
| Pubmed | 1.10e-07 | 4 | 106 | 3 | 22260870 | ||
| Pubmed | 1.10e-07 | 4 | 106 | 3 | 9382880 | ||
| Pubmed | Plasticity in the organization and sequences of human KIR/ILT gene families. | 1.10e-07 | 4 | 106 | 3 | 10781084 | |
| Pubmed | 2.74e-07 | 5 | 106 | 3 | 8812438 | ||
| Pubmed | The LILR family: modulators of innate and adaptive immune pathways in health and disease. | 2.74e-07 | 5 | 106 | 3 | 15304001 | |
| Pubmed | 5.54e-07 | 52 | 106 | 5 | 26590417 | ||
| Pubmed | 8.26e-07 | 24 | 106 | 4 | 15723811 | ||
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR51T1 OR2T29 OR10A2 OR52L1 OR13G1 OR2T5 OR52J3 OR4A16 OR10A5 | 1.05e-06 | 340 | 106 | 9 | 11875048 |
| Pubmed | OR51T1 OR2T29 OR10A2 OR52L1 OR13G1 OR2T5 OR52J3 OR4A16 OR10A5 | 1.05e-06 | 340 | 106 | 9 | 11802173 | |
| Pubmed | OR51T1 OR2T29 OR10A2 OR52L1 OR13G1 OR2T5 OR52J3 OR4A16 OR10A5 | 1.13e-06 | 343 | 106 | 9 | 32295537 | |
| Pubmed | Angiopoietin-like 2 is essential to aortic valve development in mice. | 1.16e-06 | 26 | 106 | 4 | 36414704 | |
| Interaction | LILRA3 interactions | 1.76e-07 | 11 | 99 | 4 | int:LILRA3 | |
| Interaction | SCN11A interactions | 7.17e-07 | 15 | 99 | 4 | int:SCN11A | |
| Interaction | CACNA1D interactions | 5.40e-06 | 24 | 99 | 4 | int:CACNA1D | |
| Interaction | SCN1A interactions | 1.18e-05 | 29 | 99 | 4 | int:SCN1A | |
| Interaction | LILRA1 interactions | 2.39e-05 | 2 | 99 | 2 | int:LILRA1 | |
| Cytoband | 19q13.4 | 1.17e-06 | 79 | 106 | 5 | 19q13.4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 1.21e-05 | 127 | 106 | 5 | chr2q24 | |
| Cytoband | 11p15.4 | 1.06e-04 | 200 | 106 | 5 | 11p15.4 | |
| Cytoband | 1q44 | 1.28e-04 | 110 | 106 | 4 | 1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q44 | 2.30e-04 | 128 | 106 | 4 | chr1q44 | |
| Cytoband | 2q31.3 | 4.05e-04 | 13 | 106 | 2 | 2q31.3 | |
| Cytoband | 2q24.3 | 6.20e-04 | 16 | 106 | 2 | 2q24.3 | |
| Cytoband | 6q23.3 | 1.92e-03 | 28 | 106 | 2 | 6q23.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 2.03e-03 | 564 | 106 | 6 | chr11p15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q23 | 2.70e-03 | 119 | 106 | 3 | chr6q23 | |
| Cytoband | 12q13.12 | 3.52e-03 | 38 | 106 | 2 | 12q13.12 | |
| Cytoband | Xq13.1 | 5.56e-03 | 48 | 106 | 2 | Xq13.1 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 4.18e-08 | 9 | 79 | 4 | 1203 | |
| GeneFamily | Solute carriers | SLC16A9 SLC7A11 SLC1A4 SLC1A5 SLC6A6 SLC9A4 SLC9A2 SLC7A3 SLC15A1 SLC35D3 SLC49A4 SLC22A20P | 1.37e-07 | 395 | 79 | 12 | 752 |
| GeneFamily | CD molecules|Activating leukocyte immunoglobulin like receptors | 1.59e-06 | 6 | 79 | 3 | 1181 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 5.42e-05 | 394 | 79 | 9 | 471 | |
| GeneFamily | CD molecules|Inhibitory leukocyte immunoglobulin like receptors | 1.87e-04 | 5 | 79 | 2 | 1182 | |
| GeneFamily | Protein phosphatase 6 regulatory subunits | 2.80e-04 | 6 | 79 | 2 | 699 | |
| GeneFamily | Zinc fingers MIZ-type | 3.90e-04 | 7 | 79 | 2 | 85 | |
| GeneFamily | ATP binding cassette subfamily C | 1.43e-03 | 13 | 79 | 2 | 807 | |
| GeneFamily | Sialyltransferases | 3.40e-03 | 20 | 79 | 2 | 438 | |
| Coexpression | SOUCEK_MYC_TARGETS | 8.01e-07 | 19 | 102 | 4 | MM1252 | |
| Coexpression | VALK_AML_CLUSTER_5 | 7.15e-06 | 32 | 102 | 4 | M14437 | |
| Coexpression | VERHAAK_AML_WITH_NPM1_MUTATED_UP | 8.77e-06 | 187 | 102 | 7 | M4861 | |
| Coexpression | VILIMAS_NOTCH1_TARGETS_DN | 9.16e-06 | 34 | 102 | 4 | MM791 | |
| Coexpression | GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_UP | 1.36e-05 | 200 | 102 | 7 | M6306 | |
| Coexpression | MEL18_DN.V1_UP | 1.92e-05 | 141 | 102 | 6 | M2784 | |
| Coexpression | ALK_DN.V1_UP | 1.92e-05 | 141 | 102 | 6 | M2774 | |
| Coexpression | DESCARTES_FETAL_KIDNEY_MYELOID_CELLS | 2.36e-05 | 218 | 102 | 7 | M40221 | |
| Coexpression | BMI1_DN.V1_UP | 2.43e-05 | 147 | 102 | 6 | M2782 | |
| Coexpression | GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_UP | 3.16e-05 | 154 | 102 | 6 | M6088 | |
| Coexpression | LIAN_LIPA_TARGETS_6M | 3.92e-05 | 97 | 102 | 5 | MM1016 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_CELL_AGEING | 4.34e-05 | 50 | 102 | 4 | MM3805 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_POSITIVE | LILRA1 LILRA3 LILRA2 LILRB2 STEAP4 SIRPB1 LILRB1 SLC6A6 WDFY3 | 4.39e-05 | 426 | 102 | 9 | M41019 |
| Coexpression | DESCARTES_ORGANOGENESIS_CHONDROCYTE_PROGENITORS | 1.01e-04 | 62 | 102 | 4 | MM3645 | |
| Coexpression | P53_DN.V1_DN | 1.14e-04 | 194 | 102 | 6 | M2697 | |
| Coexpression | GSE11057_PBMC_VS_MEM_CD4_TCELL_UP | 1.24e-04 | 197 | 102 | 6 | M3120 | |
| Coexpression | GSE22886_DC_VS_MONOCYTE_DN | 1.34e-04 | 200 | 102 | 6 | M4472 | |
| Coexpression | GSE7764_NKCELL_VS_SPLENOCYTE_UP | 1.34e-04 | 200 | 102 | 6 | M5720 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_8_PRECICTIVE_ICB_RESPONSE | 1.34e-04 | 200 | 102 | 6 | MM17082 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_C_D_DN | 1.82e-04 | 302 | 102 | 7 | MM1046 | |
| Coexpression | DESCARTES_FETAL_HEART_MYELOID_CELLS | 1.94e-04 | 136 | 102 | 5 | M40196 | |
| Coexpression | ZHENG_IL22_SIGNALING_UP | 2.02e-04 | 74 | 102 | 4 | MM762 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.83e-06 | 250 | 95 | 9 | gudmap_developingKidney_e13.5_podocyte cells_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#1_top-relative-expression-ranked_500 | 3.49e-06 | 142 | 95 | 7 | gudmap_developingKidney_e13.5_podocyte cells_500_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_100 | 7.25e-06 | 60 | 95 | 5 | gudmap_developingKidney_e15.5_Peripheral blastema_100_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | BOC CACNA1C IPO8 DNER STEAP4 ST8SIA1 HUWE1 PTGFR FAP SLC7A3 SCN1A SCN2A GLRB AMIGO2 | 1.62e-05 | 819 | 95 | 14 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.65e-05 | 138 | 95 | 6 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k2_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_100 | 4.46e-05 | 87 | 95 | 5 | gudmap_developingKidney_e15.5_Peripheral blastema_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.45e-05 | 217 | 95 | 7 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | ABCC4 DNER ST8SIA1 HUWE1 ITGA4 PIAS1 SLC1A4 CLDN11 CLCA2 GLRB SLC35D3 RBPJ AMIGO2 | 7.06e-05 | 818 | 95 | 13 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | alpha beta T cells, T.8SP24int.Th, 4- 8+ TCRhi 24int, Thymus, avg-3 | 8.63e-05 | 52 | 95 | 4 | GSM399382_100 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_1000 | CACNA1C MINAR2 DNER STEAP4 ST8SIA1 HUWE1 PTGFR TGM5 DOCK5 FAP CLDN11 SCN2A GNL2 | 1.10e-04 | 855 | 95 | 13 | gudmap_developingKidney_e13.5_podocyte cells_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_500 | 1.13e-04 | 421 | 95 | 9 | gudmap_developingKidney_e15.5_Peripheral blastema_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8SP69+.Th, 4- 8+ TCRhi 69+, Thymus, avg-3 | 1.33e-04 | 58 | 95 | 4 | GSM399385_100 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_500 | 1.35e-04 | 431 | 95 | 9 | gudmap_developingKidney_e13.5_podocyte cells_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_200 | 1.36e-04 | 175 | 95 | 6 | gudmap_developingKidney_e15.5_Peripheral blastema_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-vs-F_top274_274 | 1.53e-04 | 256 | 95 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_200 | 1.75e-04 | 116 | 95 | 5 | gudmap_developingKidney_e15.5_Peripheral blastema_200_k2 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | BOC LAPTM4B ST8SIA1 ITGA4 CYP39A1 PTGFR DOCK5 FAP CLDN11 GLRB RBPJ MIA | 2.11e-04 | 791 | 95 | 12 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.19e-04 | 66 | 95 | 4 | gudmap_kidney_P2_CapMes_Crym_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | ABCC4 IPO8 DNER ST8SIA1 SLC1A4 FAP CLDN11 SLC7A3 CLCA2 GLRB SLC35D3 RBPJ | 2.50e-04 | 806 | 95 | 12 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_500 | 3.29e-04 | 206 | 95 | 6 | gudmap_developingKidney_e15.5_Peripheral blastema_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.37e-04 | 207 | 95 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_500 | 3.52e-04 | 388 | 95 | 8 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.74e-04 | 211 | 95 | 6 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k1_1000 | |
| ToppCell | IPF-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 3.32e-07 | 189 | 105 | 7 | 5c22d2d935f7bb270260b8bc6be67b565ec401bf | |
| ToppCell | COPD-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 3.44e-07 | 190 | 105 | 7 | ed978cd5d9da87b49878a330e362762c487f849f | |
| ToppCell | COPD-Myeloid-ncMonocyte|COPD / Disease state, Lineage and Cell class | 3.83e-07 | 193 | 105 | 7 | 936ca95995599356b794fba32bfd82d8de339365 | |
| ToppCell | Control-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 3.83e-07 | 193 | 105 | 7 | 3479c01aaae7afd7e02d00e0cb21951c0106a0fd | |
| ToppCell | distal-Hematologic-Nonclassical_Monocyte-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.96e-07 | 194 | 105 | 7 | f1cabb198ab32deaf299899c5e8f42d861b8c574 | |
| ToppCell | distal-1-Hematologic-Nonclassical_Monocyte|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.10e-07 | 195 | 105 | 7 | e1a8171d1af53c2bbda758170c5053d3a3bb6ddd | |
| ToppCell | LAM-Myeloid-Monocyte|LAM / Condition, Lineage and Cell class | 4.10e-07 | 195 | 105 | 7 | 7ef400e068e730e18bbdb86f2daa7caf82602349 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Monocytic-Nonclassical_monocytes|lymph-node_spleen / Manually curated celltypes from each tissue | 4.39e-07 | 197 | 105 | 7 | 67f19dd30adb03300f04219d0295bc1c1788f626 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Monocytic|lymph-node_spleen / Manually curated celltypes from each tissue | 4.54e-07 | 198 | 105 | 7 | 2541f1095ed91e6789cb888cf39a208b8107726a | |
| ToppCell | severe-CD163+_Monocytes_(Sample_ID1_d7)|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.86e-07 | 200 | 105 | 7 | 4943fe826d5fcc3dfeb8b99a7415848f3fecc994 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.60e-06 | 174 | 105 | 6 | 42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-06 | 178 | 105 | 6 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.51e-06 | 181 | 105 | 6 | bad77767e64cc093a827a6b0f3f401f3f108e457 | |
| ToppCell | critical-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.51e-06 | 181 | 105 | 6 | f0d81ae74d3f32979624a94b2ef93774831a7970 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 5.12e-06 | 185 | 105 | 6 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | wk_08-11-Hematologic-Myeloid-Cycling_DC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.28e-06 | 186 | 105 | 6 | de1f0bc5dbf6dc0e716f5ebbf2bbcfe249811c54 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 5.28e-06 | 186 | 105 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.44e-06 | 187 | 105 | 6 | d17352f769c3c66601b65d060626eecff41b0482 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 5.61e-06 | 188 | 105 | 6 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.78e-06 | 189 | 105 | 6 | 235c24eeab5139f5821fccd5c879d8787682f4ef | |
| ToppCell | COPD-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 5.96e-06 | 190 | 105 | 6 | aece860b5609ad5a8fc920d685f0d0ec71bf9018 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-DC2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.96e-06 | 190 | 105 | 6 | 902afe2121593ae08d083c2cea2d1ba9f848574a | |
| ToppCell | IPF-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 5.96e-06 | 190 | 105 | 6 | f9c2a13c7f6460e3b348581be855b7281c8f70b5 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.14e-06 | 191 | 105 | 6 | 5d6ef70cc15ec5e983a953e547e40f9c06e355fb | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic-Nonclassical_monocytes|Lung / Manually curated celltypes from each tissue | 6.14e-06 | 191 | 105 | 6 | a862a571625ab7238589ff201e5954f602c3bd7e | |
| ToppCell | IPF-Myeloid-ncMonocyte|IPF / Disease state, Lineage and Cell class | 6.33e-06 | 192 | 105 | 6 | e9fb8c57d8094f70fb492909b2bec40aa5f2e5b8 | |
| ToppCell | Monocytes-Inflammatory_CD16+_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 6.33e-06 | 192 | 105 | 6 | 4be5c2c946337cd3e710137726358adca563f146 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Non-classical_Monocyte|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 6.52e-06 | 193 | 105 | 6 | 7839040e703877ef321494ad8926a8604729ceda | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic|Lung / Manually curated celltypes from each tissue | 6.52e-06 | 193 | 105 | 6 | ebe6be10ef5de9e1da988e263106698d3db42fce | |
| ToppCell | URO|World / Disease, Lineage and Cell Type | 6.52e-06 | 193 | 105 | 6 | 421dc0996c6c973f88e90197b651255ae4dd13a2 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.52e-06 | 193 | 105 | 6 | b044fca95f519ff2ceb378afe40a95911931a29e | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.52e-06 | 193 | 105 | 6 | db26b79dfe9c48388f6b64dceb21073d104ab504 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-CD16+_Monocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 6.72e-06 | 194 | 105 | 6 | ecf746ef1c5c4d6d9ca06a6d3e3778670b5700c2 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.72e-06 | 194 | 105 | 6 | e237384b02be460d44eeada3026a5691c66f6fc1 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-CD16+_Monocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.72e-06 | 194 | 105 | 6 | b133d3d198360269cc449a75d34c29be377d91e0 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.72e-06 | 194 | 105 | 6 | 0bc83ae79873a5e473e6e1e3111924cd003986a1 | |
| ToppCell | medial-Hematologic-Nonclassical_Monocyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.72e-06 | 194 | 105 | 6 | ac203d388a3a3884e316dec0dcbd408e43c6ef6c | |
| ToppCell | medial-2-Hematologic-Nonclassical_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.72e-06 | 194 | 105 | 6 | 202e5070728191c46161fa7d931f00be1c7559d4 | |
| ToppCell | medial-Hematologic-Nonclassical_Monocyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.72e-06 | 194 | 105 | 6 | 002cd317732fc6b0d9a72fb46199f71db5a638a7 | |
| ToppCell | distal-Hematologic-Nonclassical_Monocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.92e-06 | 195 | 105 | 6 | 6f417bb464b8ae6a50bbab5db5a6d5760c02122f | |
| ToppCell | cellseq-Immune-Immune_Myeloid-pMON-pMON|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.92e-06 | 195 | 105 | 6 | 2cb435dae2691e1250e26e59f9b8fb652a0c383e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-06 | 195 | 105 | 6 | 1d58585557bf8e9ce4d514e128d3a902b526331d | |
| ToppCell | distal-Hematologic-Nonclassical_Monocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.92e-06 | 195 | 105 | 6 | 935461e849ca4d17627341b3ae5124d497793a91 | |
| ToppCell | distal-2-Hematologic-Nonclassical_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.92e-06 | 195 | 105 | 6 | 34bed73e4dae34b0f1076b7ff9dc7ea2096c1796 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.92e-06 | 195 | 105 | 6 | 580ed65b4152483b642a7e7dbdf00d03588c46f6 | |
| ToppCell | Control-Myeloid-ncMonocyte|Control / Disease state, Lineage and Cell class | 6.92e-06 | 195 | 105 | 6 | fcb05948e7480dc53f06f3fc9b9c3fc129874edd | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.92e-06 | 195 | 105 | 6 | 6d60a364b8c5c3384a430b858435f5cc542d80e3 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-pMON|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.92e-06 | 195 | 105 | 6 | 217908cb53016a6cb51f1bc3fc752c8df650df71 | |
| ToppCell | Control-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 6.92e-06 | 195 | 105 | 6 | b4444b67a709e82b8e2ee510924c3152cb88b051 | |
| ToppCell | proximal-Hematologic-Nonclassical_Monocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.12e-06 | 196 | 105 | 6 | 7e136975e5943d42d51d8cc91c912547ef79cf4d | |
| ToppCell | proximal-3-Hematologic-Nonclassical_Monocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.12e-06 | 196 | 105 | 6 | e426d02c6bcff2358a45e627cc86389070a4af25 | |
| ToppCell | proximal-Hematologic-Nonclassical_Monocyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.12e-06 | 196 | 105 | 6 | 439d695526714772971fd1a4a92b8b6a84eee1a4 | |
| ToppCell | LAM-Myeloid-Monocyte|Myeloid / Condition, Lineage and Cell class | 7.12e-06 | 196 | 105 | 6 | 8165e0b5953b3639a56ebe96bb020ae52b7dbd89 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Neutrophil|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.12e-06 | 196 | 105 | 6 | 36c01e0feea33448222010c21442b9fac671bd7d | |
| ToppCell | distal-3-Hematologic-Nonclassical_Monocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.12e-06 | 196 | 105 | 6 | c1f3334bc09f5d0cfb9d998a3a64f0700426a357 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-S100A12-hi_cla._mono.|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.12e-06 | 196 | 105 | 6 | aa53ae1e5d08d31cfd81b7fae46c2b5d21d4f9b2 | |
| ToppCell | 10x5'-Liver-Myeloid_Monocytic-Nonclassical_monocytes|Liver / Manually curated celltypes from each tissue | 7.33e-06 | 197 | 105 | 6 | b0b4a704e1137f48e2258df17285ed89684ae98d | |
| ToppCell | NS-control-d_0-4-Myeloid-Non-resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.33e-06 | 197 | 105 | 6 | 496a1115071a1be6928786192de49f3adf197dfb | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.33e-06 | 197 | 105 | 6 | ec46aa307ce5774b4c0fcba64514f2d0cab3c4f9 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Monocytic-Nonclassical_monocytes|bone_marrow / Manually curated celltypes from each tissue | 7.33e-06 | 197 | 105 | 6 | dcf1e74b7c21466d38d68f44d404bce14ade2805 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_monocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.33e-06 | 197 | 105 | 6 | b91016249b3585aa3536e96af18e4f1b1d2d5ce4 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-S100A12-hi_cla._mono.|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.33e-06 | 197 | 105 | 6 | e862561f61a1ae1ec858b34f8d9c9a7dc8894104 | |
| ToppCell | medial-Hematologic-Intermediate_Monocyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.55e-06 | 198 | 105 | 6 | dbd7869483c5a67944cb94ced0ee2c7b999adc2e | |
| ToppCell | medial-Hematologic-Intermediate_Monocyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.55e-06 | 198 | 105 | 6 | 8f64bb5cd8c3e2d5ef651821b0d59f67d1ca1a12 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Monocytic-Classical_monocytes|lymph-node_spleen / Manually curated celltypes from each tissue | 7.55e-06 | 198 | 105 | 6 | 934dacb67d71faa2f8732c39d7f8e64b0ee75396 | |
| ToppCell | medial-2-Hematologic-Intermediate_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.55e-06 | 198 | 105 | 6 | 432a26ace5b486695c9a933c0d44b73305b01ded | |
| ToppCell | Sepsis-ICU-SEP-Myeloid-pDC|ICU-SEP / Disease, condition lineage and cell class | 7.55e-06 | 198 | 105 | 6 | fe8a68bff8c1b9566eee4bfcab564f206a20ae7b | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.55e-06 | 198 | 105 | 6 | d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b | |
| ToppCell | mild-HLA-DR-_S100A+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.77e-06 | 199 | 105 | 6 | d0d286eafe935f9b3aaba5b783e8911251121b4a | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_granulocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.77e-06 | 199 | 105 | 6 | 119807ea333d1dc7743c6b9f03a2c63e09e19541 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.77e-06 | 199 | 105 | 6 | 691e04871cd6cac0ea5fca1b7fd6421df9315db6 | |
| ToppCell | distal-2-Hematologic-Intermediate_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.77e-06 | 199 | 105 | 6 | 5e209df67cfe8ac7437cc363f1c5c3166bfae1af | |
| ToppCell | distal-Hematologic-Intermediate_Monocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.77e-06 | 199 | 105 | 6 | f393f8d2b9711e71beb4f1c5e7cac5acb047fd0e | |
| ToppCell | Sepsis-URO|Sepsis / Disease, condition lineage and cell class | 7.77e-06 | 199 | 105 | 6 | 8e6dac82d1d0e759cd567f9c95b70cb4801d7caf | |
| ToppCell | distal-Hematologic-Intermediate_Monocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.77e-06 | 199 | 105 | 6 | fa362f3e456a4853652e52d54e76473809eea76d | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD16|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.99e-06 | 200 | 105 | 6 | 83d9aa5b46ae7a71a258b2e44b3251f95bc9a1b7 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD16|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.99e-06 | 200 | 105 | 6 | 5ea3e74687893b8ca6cb915f0f14a14d4692775c | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Monocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.99e-06 | 200 | 105 | 6 | 7076b0db66c8f90c8f9ccfbc8bc0dcc82b15e5f3 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Monocytic-Monocyte_CD16|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.99e-06 | 200 | 105 | 6 | 94d7aa057a31287696a634d15ce91ce64af6455b | |
| ToppCell | Biopsy_IPF-Immune-Monocytes|Biopsy_IPF / Sample group, Lineage and Cell type | 7.99e-06 | 200 | 105 | 6 | 80b2b7eecc5dce9d22f9c80562e4aea83bbf0f50 | |
| ToppCell | Biopsy_Control_(H.)-Immune-Monocytes|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 7.99e-06 | 200 | 105 | 6 | c58a5dc0a0d74a21ca15ee8b7a0197de32afa045 | |
| ToppCell | severe-CD163+_Monocytes_(Sample_ID1_d7)|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.99e-06 | 200 | 105 | 6 | a3f22826f3d8f917ff0594bdadd93b60763bcaa2 | |
| ToppCell | Biopsy_Other_PF-Immune-Monocytes|Biopsy_Other_PF / Sample group, Lineage and Cell type | 7.99e-06 | 200 | 105 | 6 | 83bca55d48aae8885deb83e15b2684910e4c3358 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Intermediate_Fibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.84e-05 | 137 | 105 | 5 | dd5364a1002650d21e0c83d8c701b5f7b09d1c19 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD8-Trm_gut_CD8|Lung / Manually curated celltypes from each tissue | 2.11e-05 | 141 | 105 | 5 | 7cbe8abdd004430d58ce31e0b613894a4cf6726e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-05 | 141 | 105 | 5 | 9a0f4bee2893da1b13ab89494e6159821d53538b | |
| ToppCell | Control-Myeloid-Neutrophils|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.13e-05 | 153 | 105 | 5 | c33d63b2d1a220bc428e776b157b23faa43ea8ca | |
| ToppCell | Control-Myeloid-Neutrophils-Neutrophils|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.13e-05 | 153 | 105 | 5 | e3630f2b10f33092a3b6a63dba3a39fbdecbc7bd | |
| ToppCell | cellseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-ILC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.11e-05 | 162 | 105 | 5 | 553f91eaba72bcffb733ede45418bbee39c653ab | |
| ToppCell | moderate-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.61e-05 | 166 | 105 | 5 | c3835b424c63bf11a4e2c47635dc3787fc4a637a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.75e-05 | 167 | 105 | 5 | 31633899aae852873a4887e72c621474b0a51a33 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.17e-05 | 170 | 105 | 5 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.17e-05 | 170 | 105 | 5 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.17e-05 | 170 | 105 | 5 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | Monocytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 5.17e-05 | 170 | 105 | 5 | 4e93b66b3033e6e4d5f6d2f41974623a53108f5e | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.46e-05 | 172 | 105 | 5 | 3a76cfb2832790144a6da6406469ead0767916b5 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.61e-05 | 173 | 105 | 5 | d1e47c87bd4750801f3531f66a56c5dccb4ea64c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.61e-05 | 173 | 105 | 5 | 3aa1d28d4814798a772808ed29e1dbbdf92abd03 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.61e-05 | 173 | 105 | 5 | e8afef5ae68983eb8d6515b43952636a47e9d3d4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.93e-05 | 175 | 105 | 5 | e991ffa4d1d278a011592b9915cd35fe76db20cc | |
| Computational | Neighborhood of HCK | 7.01e-06 | 94 | 54 | 6 | GNF2_HCK | |
| Computational | Neighborhood of TNFRSF1B | 1.74e-05 | 65 | 54 | 5 | GNF2_TNFRSF1B | |
| Computational | Neighborhood of CARD15 | 2.50e-05 | 70 | 54 | 5 | GNF2_CARD15 | |
| Computational | Neighborhood of CD14 | 2.65e-05 | 35 | 54 | 4 | GNF2_CD14 | |
| Computational | Neighborhood of CD1D | 7.28e-05 | 45 | 54 | 4 | GNF2_CD1D | |
| Computational | Neighborhood of CD33 | 1.29e-04 | 52 | 54 | 4 | GNF2_CD33 | |
| Computational | Neighborhood of CASP1 | 2.27e-04 | 111 | 54 | 5 | GNF2_CASP1 | |
| Computational | Genes in the cancer module 46. | 7.20e-04 | 394 | 54 | 8 | MODULE_46 | |
| Computational | Neighborhood of S100A4 | 1.66e-03 | 47 | 54 | 3 | GNF2_S100A4 | |
| Computational | Genes in the cancer module 27. | 1.88e-03 | 355 | 54 | 7 | MODULE_27 | |
| Drug | IL-T | 2.24e-07 | 56 | 105 | 6 | CID000150551 | |
| Drug | glycine | 1.18e-06 | 169 | 105 | 8 | CID000000750 | |
| Drug | LTC4 (leukotriene C4 | 1.90e-06 | 180 | 105 | 8 | CID000003907 | |
| Drug | vinyl sulfone | 4.15e-06 | 52 | 105 | 5 | CID000006496 | |
| Drug | sodium | CACNA1C IL12A DNER HUWE1 SLC7A11 SLC1A4 SLC1A5 SLC6A6 SLC9A2 SLC7A3 LAT SLC15A1 SCN2A SCN9A SCN10A PDP2 | 6.60e-06 | 944 | 105 | 16 | CID000000923 |
| Drug | trifluoro-methyl | 8.46e-06 | 60 | 105 | 5 | CID000137518 | |
| Drug | beta-alanine | 8.77e-06 | 104 | 105 | 6 | CID000000239 | |
| Drug | harmaline | 1.78e-05 | 34 | 105 | 4 | CID000022381 | |
| Drug | diethylamidophosphate | 2.11e-05 | 2 | 105 | 2 | CID000070605 | |
| Drug | carbamazepine; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.79e-05 | 189 | 105 | 7 | 835_UP | |
| Drug | Clomipramine hydrochloride [17321-77-6]; Up 200; 11.4uM; PC3; HT_HG-U133A | 2.98e-05 | 191 | 105 | 7 | 4487_UP | |
| Drug | Val-Val | 3.10e-05 | 39 | 105 | 4 | CID000107475 | |
| Drug | FG 1 | 3.34e-05 | 14 | 105 | 3 | CID005288213 | |
| Drug | Tolbutamide [64-77-7]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 3.87e-05 | 199 | 105 | 7 | 4362_UP | |
| Drug | Chlormezanone [80-77-3]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 3.87e-05 | 199 | 105 | 7 | 5697_UP | |
| Drug | cobalt(II) chloride hexahydrate; Up 200; 100uM; MCF7; HG-U133A | 4.00e-05 | 200 | 105 | 7 | 383_UP | |
| Drug | Zonisamide | 6.18e-05 | 17 | 105 | 3 | DB00909 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 2.37e-08 | 10 | 98 | 4 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 2.37e-08 | 10 | 98 | 4 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 5.55e-08 | 12 | 98 | 4 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 2.94e-06 | 9 | 98 | 3 | C3502809 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 9.92e-06 | 13 | 98 | 3 | C0751122 | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 1.09e-05 | 2 | 98 | 2 | C4551549 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 1 measurement | 1.57e-05 | 15 | 98 | 3 | EFO_0008208 | |
| Disease | epilepsy (implicated_via_orthology) | 1.79e-05 | 163 | 98 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 3.27e-05 | 3 | 98 | 2 | C1833661 | |
| Disease | Primary Erythermalgia | 3.27e-05 | 3 | 98 | 2 | C0014805 | |
| Disease | anxiety disorder (implicated_via_orthology) | 5.23e-05 | 22 | 98 | 3 | DOID:2030 (implicated_via_orthology) | |
| Disease | nephrolithiasis (implicated_via_orthology) | 1.08e-04 | 5 | 98 | 2 | DOID:585 (implicated_via_orthology) | |
| Disease | episodic ataxia type 6 (implicated_via_orthology) | 1.62e-04 | 6 | 98 | 2 | DOID:0050994 (implicated_via_orthology) | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 2.27e-04 | 7 | 98 | 2 | C0020075 | |
| Disease | Seizure, Febrile, Simple | 2.27e-04 | 7 | 98 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 2.27e-04 | 7 | 98 | 2 | C0751057 | |
| Disease | Congenital Pain Insensitivity | 2.27e-04 | 7 | 98 | 2 | C0002768 | |
| Disease | progressive familial intrahepatic cholestasis (is_implicated_in) | 2.27e-04 | 7 | 98 | 2 | DOID:0070221 (is_implicated_in) | |
| Disease | Early Childhood Epilepsy, Myoclonic | 3.02e-04 | 8 | 98 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 3.02e-04 | 8 | 98 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 3.02e-04 | 8 | 98 | 2 | C0338479 | |
| Disease | Myoclonic Encephalopathy | 3.02e-04 | 8 | 98 | 2 | C0438414 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 3.02e-04 | 8 | 98 | 2 | C0751120 | |
| Disease | Myoclonic Absence Epilepsy | 3.02e-04 | 8 | 98 | 2 | C0393703 | |
| Disease | Febrile Convulsions | 3.87e-04 | 9 | 98 | 2 | C0009952 | |
| Disease | Myoclonic Epilepsy | 3.87e-04 | 9 | 98 | 2 | C0014550 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 3.87e-04 | 9 | 98 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | Multiple Sclerosis | 4.56e-04 | 45 | 98 | 3 | C0026769 | |
| Disease | Multiple Sclerosis, Acute Fulminating | 4.56e-04 | 45 | 98 | 3 | C0751324 | |
| Disease | Epilepsy, Myoclonic, Infantile | 4.83e-04 | 10 | 98 | 2 | C0917800 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 2 measurement | 5.89e-04 | 11 | 98 | 2 | EFO_0008209 | |
| Disease | interleukin 1 receptor-like 1 measurement | 5.89e-04 | 11 | 98 | 2 | EFO_0008168 | |
| Disease | Myoclonic Astatic Epilepsy | 5.89e-04 | 11 | 98 | 2 | C0393702 | |
| Disease | Shortened QT interval | 5.89e-04 | 11 | 98 | 2 | C0151879 | |
| Disease | hematologic cancer (implicated_via_orthology) | 8.32e-04 | 13 | 98 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | systolic blood pressure, alcohol drinking | 8.91e-04 | 128 | 98 | 4 | EFO_0004329, EFO_0006335 | |
| Disease | MMR-related febrile seizures | 1.11e-03 | 15 | 98 | 2 | EFO_0006519 | |
| Disease | interleukin 18 receptor 1 measurement | 1.11e-03 | 15 | 98 | 2 | EFO_0008178 | |
| Disease | rectum cancer, overall survival | 1.11e-03 | 15 | 98 | 2 | EFO_0000638, EFO_1000657 | |
| Disease | Neuralgia, Supraorbital | 1.27e-03 | 16 | 98 | 2 | C0038870 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 1.27e-03 | 16 | 98 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 1.27e-03 | 16 | 98 | 2 | C0423711 | |
| Disease | Neuralgia | 1.27e-03 | 16 | 98 | 2 | C0027796 | |
| Disease | Neuralgia, Atypical | 1.27e-03 | 16 | 98 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 1.27e-03 | 16 | 98 | 2 | C0234249 | |
| Disease | Paroxysmal Nerve Pain | 1.27e-03 | 16 | 98 | 2 | C0751373 | |
| Disease | Nerve Pain | 1.27e-03 | 16 | 98 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 1.27e-03 | 16 | 98 | 2 | C0751371 | |
| Disease | Neuralgia, Vidian | 1.27e-03 | 16 | 98 | 2 | C0042656 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 1.27e-03 | 16 | 98 | 2 | C0393706 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 1.61e-03 | 18 | 98 | 2 | HP_0002373 | |
| Disease | schizophrenia, inflammatory bowel disease | 1.61e-03 | 18 | 98 | 2 | EFO_0003767, MONDO_0005090 | |
| Disease | R-warfarin measurement | 1.94e-03 | 265 | 98 | 5 | EFO_0803324 | |
| Disease | leprosy, Crohn's disease | 2.00e-03 | 20 | 98 | 2 | EFO_0000384, EFO_0001054 | |
| Disease | ST2 protein measurement | 2.20e-03 | 21 | 98 | 2 | EFO_0010599 | |
| Disease | lymphocyte:monocyte ratio | 2.78e-03 | 288 | 98 | 5 | EFO_0600088 | |
| Disease | airway responsiveness measurement | 2.87e-03 | 24 | 98 | 2 | EFO_0006897 | |
| Disease | Brugada Syndrome (disorder) | 2.87e-03 | 24 | 98 | 2 | C1142166 | |
| Disease | monocyte percentage of leukocytes | 3.04e-03 | 731 | 98 | 8 | EFO_0007989 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SRSPCVVILPVIMII | 241 | Q96KV6 | |
| MSVCGAILLVLIVLL | 476 | Q9Y5Z0 | |
| RMIILPLVVCSLIGG | 101 | Q15758 | |
| PMELAIIITVPVCLL | 111 | Q8NER5 | |
| RLGGILPLVTILQCM | 151 | Q96C12 | |
| RELLCLLMITVTVGP | 21 | Q86SJ2 | |
| LIVGILGIICLILMA | 71 | P26715 | |
| MLLFTPVTIRLCEVL | 446 | Q04671 | |
| MTPILTVLICLGLSL | 1 | Q8N149 | |
| ARLDAMPVCLLLLGT | 341 | Q7L1V2 | |
| VATLIIMGLALCAIP | 376 | Q7RTY1 | |
| CRLLLDIMPGLETAV | 106 | Q9Y4B6 | |
| VDIICTTSIIPKMLG | 66 | Q8NGZ3 | |
| ITLMRRIFLIDCPGV | 351 | Q13823 | |
| MEEAILVPCVLGLLL | 1 | O43561 | |
| EVLCLEMLTLLLERP | 271 | Q9HCG8 | |
| RMVTEECPLAILILI | 136 | Q14654 | |
| MCILSGILVLALPIA | 411 | Q6PIU1 | |
| CPLLLGSVMAIERCI | 121 | P43088 | |
| RLVCILLLVVAMIGG | 136 | Q8NH70 | |
| CCVLMLLIPVTIISS | 206 | Q6IEZ7 | |
| RMVLVIGLVICIRPA | 141 | Q8NGJ9 | |
| CRMGLILLVVISILV | 166 | P59773 | |
| VIGSLLVLTMLTCLI | 411 | Q9Y6X5 | |
| DVMSVNPTCLVLIIL | 236 | Q86VI4 | |
| MTPIVTVLICLGLSL | 1 | Q8N423 | |
| MERLVLTLCTLPLAV | 1 | H3BQJ8 | |
| TLKVLIGAVPTCMIL | 456 | A6NFX1 | |
| VLVSMRLSITLSCPL | 171 | P48167 | |
| LSPSRIRLCVLVLML | 426 | O75949 | |
| MCPARSLLLVATLVL | 1 | P29459 | |
| KMVTCIAVGLPLLLI | 36 | Q96RD7 | |
| RMGCEIVIATPGRLI | 516 | Q9BUQ8 | |
| IILQLCRAALPLMSV | 1426 | Q9Y4D8 | |
| LRGLSRTILMCGPLI | 526 | Q8IZL8 | |
| TVLIRACVSMLGVPV | 1756 | Q7Z6Z7 | |
| AIVGTILVVMIPCLL | 186 | Q9H208 | |
| LCCVIMLLIPVTVIS | 201 | Q8NGZ9 | |
| CCVLMLLIPVTIISS | 206 | Q8NH02 | |
| VMIPGLLRCSVGAIR | 6 | Q96HP4 | |
| SCLAGMAVLIILLPL | 236 | O15439 | |
| LACRVMDPTKILITG | 636 | Q58A45 | |
| LLRCLQAPLETVVMT | 286 | O95522 | |
| TIIMEDRLLGVLIPC | 331 | Q9P2J9 | |
| IILCVMAGIIGTILL | 66 | P06028 | |
| GMRPEVTLACLLLAT | 11 | Q9BWV1 | |
| MSPLGISVLRCVRLL | 611 | Q13936 | |
| SMDLIRPRVSLVCQI | 286 | Q9H7D0 | |
| VPIISQCGDMLVRSL | 146 | Q9HB55 | |
| LMVLGTGLRCIPISD | 126 | Q96SL1 | |
| ILLLLTVLPCIRMGQ | 96 | O75508 | |
| VRETVMLLLCLGVPT | 16 | P13612 | |
| MGIVRTSPCLTLPDV | 71 | Q8NEG0 | |
| MELISPTVIIILGCL | 1 | Q9NYL5 | |
| ILMLIILIVGICRIS | 651 | Q8NFT8 | |
| LAVCVLTETRNMPLV | 501 | A6NK97 | |
| LSTIITPMLRVQQCG | 176 | P46059 | |
| QRSIPMGIVISLSVC | 281 | Q8WY07 | |
| RIVLTEGTPTMLCLA | 1261 | Q5VW36 | |
| ALMDLLLRLVSCVEP | 161 | O75170 | |
| MTPILTVLICLGLSL | 1 | Q8N6C8 | |
| IVGTILVVMIPCLLI | 201 | Q9H207 | |
| IRSPDLVRVQLTMCL | 101 | O15397 | |
| RLVMVKVVPTCLRAL | 361 | Q14653 | |
| MARSLVCLGVIILLS | 1 | Q16674 | |
| ISMCIVIRPVLLTLP | 146 | Q8NH60 | |
| CIGMVVLVRGLLLLI | 161 | Q8NGH7 | |
| VFKRCLPLVTMLIGV | 106 | Q5M8T2 | |
| LSSMLCVPLVIVIRL | 551 | P31641 | |
| TLLTRPSIQMRLCCI | 81 | O14599 | |
| VLLLLVCTPLGLARM | 206 | Q6UX01 | |
| MTPIVTVLICLRLSL | 1 | O75019 | |
| MTPILTVLICLGLSL | 1 | Q8NHL6 | |
| GAIPSIMNVLLVCLI | 1316 | Q15858 | |
| LMPESCLLILVGALV | 96 | Q6AI14 | |
| TRLPMGASALCVVVL | 26 | Q92185 | |
| ARVLTCVEGMNLPLL | 91 | Q86WV5 | |
| VSLLCPLGKMRLTIP | 331 | O75925 | |
| ILCIIMAAIGPVILI | 131 | Q96J65 | |
| LGAIPSIMNVLLVCL | 1341 | P35498 | |
| CMRTGIIFIPATILL | 131 | Q08AH1 | |
| VLTAMGLIGIICLII | 906 | Q9UQC9 | |
| RVLMNCPEIVTIGLV | 236 | Q70EK8 | |
| TLRCAMTSLIPVGPI | 51 | O00241 | |
| VLALLVMCIVLRPSR | 16 | Q12884 | |
| IPLAICISMAIVTIG | 266 | Q9UPY5 | |
| LLSMVPRPVCAVLLL | 41 | P15374 | |
| MKAPGRLVLIILCSV | 1 | Q9H4F1 | |
| ARIIMLIVIAPIVCS | 496 | O95497 | |
| MRVLIIDNLCLTPAS | 1966 | Q8IZQ1 | |
| LRVMPCLEAVALILL | 206 | Q6ZMD2 | |
| TIVPESCLLIMVGLL | 106 | Q9UBY0 | |
| LRMIILPLVVCSLVS | 86 | P43007 | |
| GAIPSIMNVLLVCLI | 1276 | Q9Y5Y9 | |
| LGAIPSIMNVLLVCL | 1331 | Q99250 | |
| VLIMPCVDNTLTRIR | 436 | Q687X5 | |
| CTVMRCLGIPTRVIT | 286 | O43548 | |
| RVSLICPLVKMRLSV | 321 | Q8N2W9 | |
| VCSVTGMALPRLIIR | 251 | Q06330 | |
| SIVRIIGKMLPLEPC | 36 | Q6P444 | |
| PVVVENITLMCLRIL | 4006 | Q5T4S7 | |
| AIMDLLLRLLTCIEP | 161 | Q5H9R7 | |
| KGMPVRLLSEVTCLL | 416 | Q6WRX3 | |
| MAPQTLLLVLVLCVL | 1 | Q8IUB3 | |
| VSPIESLRLMCLLSI | 391 | Q9H267 | |
| AILIPVVFMGCLRIL | 416 | Q9NS93 |